A Hakim1, C Kurmann2, K Pospieszny2, T R Meinel3, M A Shahin4, M R Heldner3, R Umarova3, S Jung3, M Arnold3, M El-Koussy2. 1. From the University Institute of Diagnostic and Interventional Neuroradiology (A.H., C.K., K.P., M.E.), Bern University Hospital, Inselspital, Inselspital, University of Bern, Bern, Switzerland arsany_hakim@yahoo.com. 2. From the University Institute of Diagnostic and Interventional Neuroradiology (A.H., C.K., K.P., M.E.), Bern University Hospital, Inselspital, Inselspital, University of Bern, Bern, Switzerland. 3. Department of Neurology (T.R.M., M.R.H., R.U., S.J., M.A.), Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland. 4. Department of Radiodiagnosis (M.A.S.), Faculty of Medicine, Cairo University Hospitals, Cairo, Egypt.
Abstract
BACKGROUND AND PURPOSE: Assessment of cerebral venous sinus thrombosis on MR imaging can be challenging. The aim of this study was to evaluate the diagnostic accuracy of high-resolution 3D T2 sampling perfection with application-optimized contrasts by using different flip angle evolution (SPACE) in patients with cerebral venous sinus thrombosis and to compare its performance with contrast-enhanced 3D T1-MPRAGE. MATERIALS AND METHODS: We performed a blinded retrospective analysis of T2-SPACE and contrast-enhanced MPRAGE sequences from patients with cerebral venous sinus thrombosis and a control group. The results were compared with a reference standard, which was based on all available sequences and clinical history. Subanalyses were performed according to the venous segment involved and the clinical stage of the thrombus. RESULTS: Sixty-three MR imaging examinations from 35 patients with cerebral venous sinus thrombosis and 51 examinations from 40 control subjects were included. The accuracy, sensitivity, and specificity calculated from the initial MR imaging examination for each patient were 100% each for T2-SPACE and 95%, 91%, and 98%, respectively, for contrast-enhanced MPRAGE. The interrater reliability was high for both sequences. In the subanalysis, the accuracy for each venous segment involved and if subdivided according to the clinical stage of thrombus was ≥95% and ≥85% for T2-SPACE and contrast-enhanced MPRAGE, respectively. CONCLUSIONS: Both T2-SPACE and contrast-enhanced MPRAGE offer high accuracy for the detection and exclusion of cerebral venous sinus thrombosis; however, T2-SPACE showed a better overall performance and thus could be a useful tool if included in a multiparametric MR imaging protocol for the diagnosis of cerebral venous sinus thrombosis, especially in scenarios where gadolinium administration is contraindicated.
BACKGROUND AND PURPOSE: Assessment of cerebral venous sinus thrombosis on MR imaging can be challenging. The aim of this study was to evaluate the diagnostic accuracy of high-resolution 3D T2 sampling perfection with application-optimized contrasts by using different flip angle evolution (SPACE) in patients with cerebral venous sinus thrombosis and to compare its performance with contrast-enhanced 3D T1-MPRAGE. MATERIALS AND METHODS: We performed a blinded retrospective analysis of T2-SPACE and contrast-enhanced MPRAGE sequences from patients with cerebral venous sinus thrombosis and a control group. The results were compared with a reference standard, which was based on all available sequences and clinical history. Subanalyses were performed according to the venous segment involved and the clinical stage of the thrombus. RESULTS: Sixty-three MR imaging examinations from 35 patients with cerebral venous sinus thrombosis and 51 examinations from 40 control subjects were included. The accuracy, sensitivity, and specificity calculated from the initial MR imaging examination for each patient were 100% each for T2-SPACE and 95%, 91%, and 98%, respectively, for contrast-enhanced MPRAGE. The interrater reliability was high for both sequences. In the subanalysis, the accuracy for each venous segment involved and if subdivided according to the clinical stage of thrombus was ≥95% and ≥85% for T2-SPACE and contrast-enhanced MPRAGE, respectively. CONCLUSIONS: Both T2-SPACE and contrast-enhanced MPRAGE offer high accuracy for the detection and exclusion of cerebral venous sinus thrombosis; however, T2-SPACE showed a better overall performance and thus could be a useful tool if included in a multiparametric MR imaging protocol for the diagnosis of cerebral venous sinus thrombosis, especially in scenarios where gadolinium administration is contraindicated.
Authors: D Patel; M Machnowska; S Symons; R Yeung; A J Fox; R I Aviv; P Jabehdar Maralani Journal: AJNR Am J Neuroradiol Date: 2016-06-16 Impact factor: 3.825
Authors: F Al-Mufti; K Amuluru; R Sahni; K Bekelis; R Karimi; J Ogulnick; J Cooper; P Overby; R Nuoman; A Tiwari; K Berekashvili; N Dangayach; J Liang; G Gupta; P Khandelwal; J F Dominguez; T Sursal; H Kamal; K Dakay; B Taylor; E Gulko; M El-Ghanem; S A Mayer; C Gandhi Journal: AJNR Am J Neuroradiol Date: 2021-04-22 Impact factor: 4.966
Authors: José M Ferro; Martin Bendszus; Olav Jansen; Jonathan M Coutinho; Francesco Dentali; Adam Kobayashi; Diana Aguiar de Sousa; Lia L Neto; Corinna Miede; Jorge Caria; Holger Huisman; Hans-Christoph Diener Journal: Int J Stroke Date: 2021-04-04 Impact factor: 5.266